Resmed (RMD) FCF Payout Ratio Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -80.40% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -13.02% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -0.55% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | - |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -47.89% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -21.80% |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.02% |
| Dec 31, 2025 | -23.83% |
| Sep 30, 2025 | -62.84% |
| Jun 30, 2025 | -49.83% |
| Mar 31, 2025 | -46.11% |
| Dec 31, 2024 | -5.85% |
| Sep 30, 2024 | 33.60% |
| Jun 30, 2024 | -15.93% |
| Mar 31, 2024 | -17.86% |
| Dec 31, 2023 | -12.28% |
| Sep 30, 2023 | -13.99% |
| Jun 30, 2023 | 20.79% |
| Mar 31, 2023 | -1.74% |
| Dec 31, 2022 | -20.19% |
| Sep 30, 2022 | 117.50% |
| Jun 30, 2022 | 39.65% |
| Mar 31, 2022 | 27.88% |
| Dec 31, 2021 | -12.06% |
| Sep 30, 2021 | -34.59% |
| Jun 30, 2021 | -13.83% |
| Mar 31, 2021 | -3.10% |
| Dec 31, 2020 | -0.62% |
| Sep 30, 2020 | -12.10% |
| Jun 30, 2020 | -22.18% |
| Mar 31, 2020 | -32.71% |
| Dec 31, 2019 | 41.52% |
| Sep 30, 2019 | -14.72% |
| Jun 30, 2019 | 10.68% |
| Mar 31, 2019 | 4.20% |
| Dec 31, 2018 | 16.90% |
| Sep 30, 2018 | 56.93% |
| Jun 30, 2018 | -0.26% |
| Mar 31, 2018 | -9.18% |
| Dec 31, 2017 | -1.79% |
| Sep 30, 2017 | 2.32% |
| Jun 30, 2017 | 1.97% |
| Mar 31, 2017 | 27.68% |
| Dec 31, 2016 | -7.19% |
| Sep 30, 2016 | 10.34% |
| Jun 30, 2016 | 13.36% |
| Mar 31, 2016 | 10.54% |
| Dec 31, 2015 | -2.77% |
| Sep 30, 2015 | 3.13% |